investordatabase.org

Avicella Capital

avicellacapital.com Direct investor

Avicella Capital is a venture investor focused on early-stage healthcare assets, including therapeutics, medical devices, diagnostics and health tech. It states that it invests in medical technologies and therapies with proof-of-concept.

Avicella Capital is a venture capital firm. It invests directly in companies, from seed to Series A, in therapeutics, medical devices, diagnostics and health tech.

“Our fundamental purpose is to find and invest in early-stage assets, which improve patient outcomes, increase quality of healthcare, and prolong human longevity.”

— Avicella Capital, own website
Layer
Direct investor
Type
Venture capital
Stage
Seed – Series A
Sectors
therapeutics, medical devices, diagnostics, health tech
How to reach it
Its contact page on its own site

Team, as Avicella Capital publishes it

  • Gennady Bratslavsky, MD Founder & Managing Partner
  • Brooke Raphael Partner & COO
  • David Saab Co-Founder & Partner

Names and roles exactly as listed on avicellacapital.com. Nothing else about these people is recorded.

Named by events

Each event below names or links Avicella Capital on its own website — as the firm of a speaker, a partner or a listed investor. The event is the source, not the investor; it says nothing about who will be in the room.

Where this comes from

Every fact above was read from a page Avicella Capital publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale?
— it reaches us directly, no email address to look up.

Record 22127 · added 2026-11-17 · link last verified 2026-11-17 · confidence medium

Similar investors

Listed under